(261 days)
No
The device description focuses on the physical and chemical properties of the bone putty and its mechanical function as a barrier. There is no mention of AI, ML, or any computational processing.
Yes.
The device's intended use is to control bleeding from cut or damaged bone during surgical procedures and in treating traumatic injuries, which is a therapeutic function.
No
Explanation: The device, Orthocon OrthoStat™ Hemostatic Bone Putty, is indicated for use in the control of bleeding from cut or damaged bone by acting as a mechanical barrier or tamponade. This function addresses a physiological condition (bleeding) rather than identifying or analyzing a disease, injury, or medical condition.
No
The device description clearly states it is a physical material (putty) composed of calcium stearate, Vitamin E Acetate, and alkylene oxide copolymer, intended for manual application. It is not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Function: The Orthocon OrthoStat™ Hemostatic Bone Putty is a material applied directly to bone to control bleeding. It acts as a mechanical barrier.
- Lack of Specimen Analysis: The device does not involve the analysis of any biological specimens taken from the patient. Its function is purely mechanical and local to the surgical site.
Therefore, based on its intended use and mechanism of action, the Orthocon OrthoStat™ Hemostatic Bone Putty falls under the category of a surgical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Orthocon OrthoStat™ Hemostatic Bone Putty is indicated for use in the control of bleeding from cut or damaged bone by acting as a mechanical barrier or tamponade. The material may be used during surgical procedures and in treating traumatic injuries.
Product codes
MTJ
Device Description
Orthocon OrthoStat™ Hemostatic Bone Putty is a sterile, soft, moldable, biocompatible, absorbable material of putty-like consistency intended for use in the management of bleeding from the cut surface of bone. The material is a mixture of calcium stearate (a wax-like tamponade), Vitamin E Acetate (for handling properties) and alkylene oxide copolymer (a dispersing agent). The material is virtually odorless, off-white in color and can be spread easily with minimal adhesion to surgical gloves. The bone putty requires no kneading prior to application and does not soften appreciably at body temperature. When applied manually to surgically incised or traumatically broken bone, OrthoStat Hemostatic Bone Putty achieves local control of bleeding by acting as a mechanical barrier (tamponade). The bone putty will be dispersed and absorbed within a period of 60 days.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bone
Indicated Patient Age Range
Not Found
Intended User / Care Setting
surgical procedures, treating traumatic injuries
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The 510(k) Notice contains summaries of physical test results, functionality (efficacy testing) results, absorption testing and biocompatibility testing. The data presented demonstrate that the device is biocompatible and is suitable for its indicated use. The single-patient-use OrthoStat™ Hemostatic Bone Putty is provided sterile.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
N/A
0
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS (Per 21 CFR 807.92)
General Company Information
| Name: | Orthocon, LLC |
|---|---|
| Contact: | Howard Schrayer |
| Regulatory Affairs Consultant |
- Address: 167 Stone Hill Road Colts Neck, NJ 07722
- Telephone: (732) 683 - 9304 Fax: (732) 683 - 9476
- July 21, 2005 Date Prepared
General Device Information
| Product Name: | OrthoStat™ Hemostatic Bone Putty |
|---|---|
| Classification: | "Bone Wax", Product code: MTJ |
| Unclassified |
Predicate Devices
CP Medical, Inc. - CP Medical Bone Wax 510(k) Number K024372
Ethicon, Inc. Bone Wax - Pre-enactment
United States Surgical Corporation Bone Wax 510(k) Number K971680 (Absorbable)
Ceremed AOC Bone Wax 510(k) Number K041363 (Absorbable)
Description
Orthocon OrthoStat™ Hemostatic Bone Putty is a sterile, soft, moldable, biocompatible, absorbable material of putty-like consistency intended for use in the management of bleeding from the cut surface of bone. The material is a mixture of calcium stearate (a wax-like tamponade), Vitamin E Acetate (for handling properties) and alkylene oxide
1
K043260 page 2/2
Page 98 of 98
copolymer (a dispersing agent). The material is virtually odorless, off-white in color and can be spread easily with minimal adhesion to surgical gloves. The bone putty requires no kneading prior to application and does not soften appreciably at body temperature.
When applied manually to surgically incised or traumatically broken bone, OrthoStat Hemostatic Bone Putty achieves local control of bleeding by acting as a mechanical barrier (tamponade). The bone putty will be dispersed and absorbed within a period of 60 days.
Intended Use (Indications)
Orthocon OrthoStat™ Hemostatic Bone Putty is indicated for use in the control of bleeding from cut or damaged bone by acting as a mechanical barrier or tamponade. The moterial may be used during surgical procedures and in treating traumatic injuries.
Substantial Equivalence
This submission supports the position that the Orthocon OrthoStat™ Hemostatic Bone Putty is substantially equivalent to a number of pre-enactment and previously cleared devices, including:
CP Medical Bone Wax - [501(k) Number K032930] Lukens Bone Wax - [510(k) K791495] Aesculap Bone Wax - [510(k) K000021] Ethicon Bone Wax - Pre-enactment United States Surgical Corporation Bone Wax – [510(k) Number K971680] (Absorbable) Ceremed AOC Bone Wax - [510(k) Number K041363] (Absorbable)
The 510(k) Notice contains summaries of physical test results, functionality (efficacy testing) results, absorption testing and biocompatibility testing.
The data presented demonstrate that the device is biocompatible and is suitable for its indicated use. The single-patient-use OrthoStat™ Hemostatic Bone Putty is provided sterile.
Conclusions
Orthocon, LLC believes that the information provided establishes that similar legally marketed devices have been used for the same clinical applications as the Orthgoon OrthoStat™ Hemostatic Bone Putty. The materials from which the Orthocon device is fabricated have an established history of use, and the devices have been tested in accordance with applicable FDA guidelines.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image contains the text "Public Health Service". The text is in a simple, sans-serif font and is horizontally oriented. The text is black against a white background.
Image /page/2/Picture/2 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized eagle with three lines forming its body and head. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES USA" are arranged in a circular pattern around the eagle. The seal is black and white and appears to be a scanned image.
AUG 1 1 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Howard L. Schrayer Regulatory Affairs Consultant Orthocon, LLC 167 Stone Hill Road Colts Neck, New Jersey 07722
Re: K043260
Trade/Device Name: Orthocon, OrthoStat™ Hemostatic Bone Putty Regulatory Class: Unclassified Product Code: MTJ Dated: July 22, 2005 Received: July 25, 2005
Dear Mr. Schrayer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mr. Howard L. Schrayer
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please in Joan Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours,
Soubare Buechd
M. N. Mcllwraith
Mark N. Melkerso Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K043260
Device Name: Orthocon, OrthoStat™ Hemostatic Bone Putty
Indications For Use:
The Orthocon OrthoStat™ Hemostatic Bone Putty is indicated for use in the control of bleeding from cut or damaged bone by acting as a mechanical barrier or tamponade. The material may be used during surgical procedures and in treating traumatic injuries.
Prescription Use
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
bare Bnechuf for Mettorson
(Division Sign-Off)
Division of General, Restorative and Neurological Devices
510(k) Number K043260